Castle Biosciences Inc
NASDAQ:CSTL

Watchlist Manager
Castle Biosciences Inc Logo
Castle Biosciences Inc
NASDAQ:CSTL
Watchlist
Price: 16.08 USD -4.29% Market Closed
Market Cap: 464.2m USD

Intrinsic Value

The intrinsic value of one CSTL stock under the Base Case scenario is 25.34 USD. Compared to the current market price of 16.08 USD, Castle Biosciences Inc is Undervalued by 37%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CSTL Intrinsic Value
25.34 USD
Undervaluation 37%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Castle Biosciences Inc

What is Valuation History?
Compare CSTL to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CSTL?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Castle Biosciences Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Castle Biosciences Inc

Current Assets 349.4m
Cash & Short-Term Investments 275.2m
Receivables 56.4m
Other Current Assets 17.9m
Non-Current Assets 152.3m
Long-Term Investments 5.6m
PP&E 66.6m
Intangibles 77.9m
Other Non-Current Assets 2.3m
Efficiency

Free Cash Flow Analysis
Castle Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Castle Biosciences Inc

Revenue
347.1m USD
Cost of Revenue
-62.7m USD
Gross Profit
284.4m USD
Operating Expenses
-298.2m USD
Operating Income
-13.8m USD
Other Expenses
8.7m USD
Net Income
-5.1m USD
Fundamental Scores

CSTL Profitability Score
Profitability Due Diligence

Castle Biosciences Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
36/100
Profitability
Score

Castle Biosciences Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

CSTL Solvency Score
Solvency Due Diligence

Castle Biosciences Inc's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

Castle Biosciences Inc's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CSTL Price Targets Summary
Castle Biosciences Inc

Wall Street analysts forecast CSTL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CSTL is 36.61 USD with a low forecast of 30.3 USD and a high forecast of 43.05 USD.

Lowest
Price Target
30.3 USD
88% Upside
Average
Price Target
36.61 USD
128% Upside
Highest
Price Target
43.05 USD
168% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Castle Biosciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CSTL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CSTL Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one CSTL stock?

The intrinsic value of one CSTL stock under the Base Case scenario is 25.34 USD.

Is CSTL stock undervalued or overvalued?

Compared to the current market price of 16.08 USD, Castle Biosciences Inc is Undervalued by 37%.

Back to Top